GlassScriptPhysician profile
Ian Michael Mcgrath
NPI 1205323532
$1,219.63
in general payments reported to CMS, 2019-2025
10 companies · $565 in 2025
The $565 reported for 2025 was more than what 91% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $24.21 · 2023: $250 · 2024: $380 · 2025: $565.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,195.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $231.19 | 2025 | Hemosphere |
| Abiomed | $162.51 | 2023-2025 | Impella |
| Abbott Laboratories | $143.98 | 2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| La Jolla Pharmaceutical Company | $138.60 | 2024 | Giapreza |
| Ethicon US, LLC | $122.50 | 2025 | Surgicel Nu-Knit |
| Boston Scientific Corporation | $119.23 | 2023 | Watchman Access System |
| Bolton Medical INC | $107.61 | 2025 | Treo Abdominal Stent-Graft System |
| Edwards Lifesciences Corporation | $107.51 | 2022-2024 | Hemosphere |
| Medtronic, INC. | $56.11 | 2025 | Retia Medical |
| Merck Sharp & Dohme LLC | $30.39 | 2023-2024 | Bridion |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ian Mcgrath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.